Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Costamare Maintains Quarterly Dividend at $0.115 Per Common Share, Payable May 6 to Shareholders of Record April 17
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Costamare Maintains Quarterly Dividend at $0.115 Per Common Share, Payable May 6 to Shareholders of Record April 17
Apr 2, 2025 8:16 AM
10:43 AM EDT, 04/02/2025 (MT Newswires) --
Price: 10.21, Change: -0.06, Percent Change: -0.58
Previous page:
Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial
Next page:
Target Hit By Traffic, Profit Decline Heading Into Holiday Season
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial
Nov 19, 2025
Nov 19 (Reuters) - Merck ( MRK ) said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy in a late-stage study in adults with HIV who had not previously received treatment. The Rahway, New Jersey-based company was testing its oral, two-drug regimen of doravirine and islatravir in adults with HIV-1 infection...
Target Hit By Traffic, Profit Decline Heading Into Holiday Season
Nov 19, 2025
Target Corporation ( TGT ) stock slipped in early trading on Thursday as the retailer reported a third-quarter profit beat but posted underwhelming sales and trimmed its full-year earnings outlook heading into the crucial holiday stretch. At the same time, the big-box chain is leaning into an attention-grabbing artificial intelligence push, wiring its aisles into ChatGPT through an expanded OpenAI...
Regeneron Pharmaceuticals Gets European Commission's Approval for Expanded Indication for Libtayo
Nov 19, 2025
08:32 AM EST, 11/19/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday it has received the European Commission's approval for its PD-1 inhibitor Libtayo as an adjuvant treatment for adult patients with cutaneous squamous cell carcinoma. The approval expands the existing EU indication for Libtayo to include patients at high risk of disease recurrence after surgery and radiation,...
Troilus Gold Upsizes Debt Financing Mandate to US$1 Billion
Nov 19, 2025
08:33 AM EST, 11/19/2025 (MT Newswires) -- Troilus Gold ( CHXMF ) on Wednesday increased its previously announced debt financing mandate to up to US$1 billion from $700 million. The company said the financing will support the development and construction of the copper-gold Troilus project, located in north-central Quebec, Canada. Auramet International is acting as project finance advisor. It said...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP